WHO ICTRP trial
Validation study of new febrile neutropenia guideline-Comparative study between…
JPRN-C000000396 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-C000000396 |
|---|---|
| Public title | Validation study of new febrile neutropenia guideline-Comparative study between oral levofloxacin and parenteral cefepime in low-risk patients with febrile neutropenia |
| Scientific title | Validation study of new febrile neutropenia guideline-Comparative study between oral levofloxacin and parenteral cefepime in low-risk patients with febrile neutropenia - Treatment for FN in Low-Risk patients |
| Primary sponsor | Japan Febrile Neutropenia Study Group |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase III |
| Countries | Japan |
| Conditions | Febrile neutropenia |
| Interventions | CFPM 4g,1h-div, q12 LVFX 200mg, tid |
| Registration date | Apr 4, 2006 |
| Target size | 200 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: